The eosinophil and the eye

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 34, 1997, Pages 44-47

  Bonini, Se ^a,e   Magrini, L ^b   Rotirati, G ^b   Lambiase, A ^c   Tomassini, M ^b   Rumi, C ^d   Bonini, St ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e CNR   (Italy)

Author keywords

Allergic conjunctivitis; Cetirizine; Conjunctival allergen challenge; Eosinophil; Vernal keratoconjunctivitis

Indexed keywords

ALLERGEN; CETIRIZINE; PROTEIN;

ALLERGIC CONJUNCTIVITIS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VERNAL CONJUNCTIVITIS;

CETIRIZINE; CONJUNCTIVITIS, ALLERGIC; EOSINOPHILS; EYE; HISTAMINE H1 ANTAGONISTS; HUMANS; KERATOCONJUNCTIVITIS; TEARS;

EID: 0030977348     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04810.x     Document Type: Article

References (25)

1. Kay AB Ed. Eosinophils, allergy and asthma. Oxford: Blackwell Scientific Publishers, 1990.
2. Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl Med 1990;323:1033-9.
3. Bonini S, Bonini S, Berruto A, Tomassini M, Carlesimo S, Bucci MG, et al. Conjunctival provocation test as a model for the study of allergy and inflammation in humans. Int Arch Allergy Appi Immunol 1989;88:144-8.
4. Bonini S, Bonini S, Lambíase A, Magrini L, Runi C, Del Preti G, et al. Vernal keratoconjunctivitis: a model of C5q cytokine gene cluster disease. Int Arch Allergy Appi Immunol 1995;107:95-8.
5. Bonini S, Tomassini M, Bonini S, et al. The eosinophil has a pivotal role in allergic inflammation of the eye. Int Arch Allergy Appi Immunol 1992;99:354-8.
6. Bonini S, Lambíase A, Schiavone M, et al. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology 1995;102:1374-9.
7. Magrini L, Metz D, Bacon A, et al. Immunohistochemistry and inflammation of vernal keratoconjunctivitis. Abs. Invest Ophthalmol Vis Sci 1993;34:857.
8. Bonini S, Barney NP, Schiavone M, Centofanti M, Berruto A, Bonini S, et al. Effectiveness of nedocromil sodium 2% eye drops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye 1992;6:648-52.
9. Bonini S, Bonini S, Schiavone M, Centofanti, Allansmith MR, Bucci MG. Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis. J Allergy Clin Immunol 1992;89:103-7.
10. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610-13.
11. Borrirli S, Bonini S, Vecchione A, Nairn DM, Allansmith R, Balsano F. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 1988;82:462-9.
12. Bonini S, Bonini S, Bucci MG, Berruto A, Adriani E, Balsano F, et al. Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol 1990;86:869-76.
13. Bonini S, Centofanti M, Schiavone M, et al. The pattern of ocular late phase reaction induced by allergen challenge in hay fever conjunctivitis. Ocular Immunol Inflamm 1994; 2:195-7.
14. Rotiroti G, Magrini L, Onorati P, et al. IL-5 in tears of vernal keratoconjunctivitis patients. Allergy 1995;50:180.
15. Desremaux P, Jarnin A, Colombel JF, Prin L, Plumas J, Emilie D, et al. Interleukin-5 messenger-RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992;175:293-6.
16. Desremaux P, Jarnin A, Dubucqoui S, Copin MC, Torpier G, Capron A, et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1993;82:1553-60.
17. Takatsu K. Interleukin-5. Curr Opinion Immunol 1992;4: 299-306.
18. Tomassini M, Magrini L, Bonini S, Lambiate A, Bonini S. Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis. Ophthalmology 1994;101:1808-11.
19. Rutella S, Bonini St, Rumi C, et al. Flow cytometry of peripheral blood leucocytes in vernal keratoconjunctivitis. Abs. J Allergy Clin Immunol 1995;95:376.
20. Campoli-Richards DM, Buckley MM-T, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs 1990;40:762-81.
21. Masi M, Candiani R, van de Venne H. A placebo-controlled trial of cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years. Pediatr Allergy Immunol 1993; Suppl 4:47-52.
22. Leprevost C, Capron M, De Vos C, Tomassini M, Capron A. Inhibition of eosinophil chemotaxis by a new anti-allergic compound (cetirizine). Int Arch Allergy Appi Immunol 1988;87:9-13.
23. Sehmi R, Walsh GM, Hartnell A, Barkans J, North J, Kay AB, et al. Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro. Pediatr Allergy Immunol 1993;Suppl 4:13-18.
24. Fadel F, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCL on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
25. Trocme SD, Aldave AJ. The eye and eosinophil. Survey Ophthalmol 1994;39:241-52.